Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Suisse (CSUI) EBITDA (2016 - 2025)

Historic EBITDA for Cannabis Suisse (CSUI) over the last 10 years, with Q4 2025 value amounting to -$73919.0.

  • Cannabis Suisse's EBITDA rose 1899.11% to -$73919.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$276136.0, marking a year-over-year increase of 1049.71%. This contributed to the annual value of -$283769.0 for FY2025, which is 1229.79% down from last year.
  • Cannabis Suisse's EBITDA amounted to -$73919.0 in Q4 2025, which was up 1899.11% from -$83474.0 recorded in Q3 2025.
  • In the past 5 years, Cannabis Suisse's EBITDA registered a high of $59173.0 during Q1 2021, and its lowest value of -$674320.0 during Q2 2021.
  • Moreover, its 5-year median value for EBITDA was -$61907.5 (2023), whereas its average is -$90129.8.
  • Within the past 5 years, the most significant YoY rise in Cannabis Suisse's EBITDA was 19693.98% (2021), while the steepest drop was 466214.69% (2021).
  • Over the past 5 years, Cannabis Suisse's EBITDA (Quarter) stood at -$40769.0 in 2021, then surged by 30.55% to -$28314.0 in 2022, then plummeted by 75.32% to -$49641.0 in 2023, then plummeted by 83.82% to -$91248.0 in 2024, then grew by 18.99% to -$73919.0 in 2025.
  • Its EBITDA was -$73919.0 in Q4 2025, compared to -$83474.0 in Q3 2025 and -$53016.0 in Q2 2025.